ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
iBio Signs License Agreement with Planet Biotechnology for COVID-19 Therapeutic
September 02, 2020iBio Inc., a biotechnology innovator and biologics contract manufacturing organization, has entered into an exclusive worldwide license agreement with Planet Biotechnology Inc. for the development of Planet’s COVID-19 therapeutic candidate, ACE2-Fc.
Pharma Sources Insight January 2025
